People with type 2 diabetes don't need to test their blood at home
if they have well controlled symptoms and don't take medications
that can cause dangerously low blood sugar, doctors say. For these
patients, studies have not found that home blood sugar monitoring
makes any difference in blood sugar levels. But still, many of them
are pricking their fingers unnecessarily.
For the current study, researchers examined data on more than
370,000 people with type 2 diabetes. Overall, almost 88,000, or
about 23 percent, had at least three insurance claims for test
strips used to check blood sugar at home.
More than half of the people testing their blood sugar at home
didn't need to do this, accounting for 14 percent of the total study
population, researchers reported in JAMA Internal Medicine.
"Many type 2 diabetes patients not using insulin or other
medications at risk of rapid changes in blood sugar levels are
testing far more often then they need to be," said lead study author
Dr. Kevin Platt of the University of Michigan in Ann Arbor.
"This needless behavior causes unnecessary pokes, worry, and costs,"
Platt said by email. "More is not always better when it comes to
medical care."
Type 2 diabetes, the most common form of the disease, is linked to
obesity and aging and happens when the body can't properly use or
make enough of the hormone insulin to convert blood sugar into
energy. Left untreated, it can lead to complications like blindness,
kidney failure, nerve damage, and amputations.
Many patients can keep their blood sugar in a healthy range with
oral medications and don't need insulin. Unlike insulin, which
immediately affects blood sugar and requires regular testing to
ensure blood sugar is in a healthy range, most pills for diabetes
don't require regular testing because they don't cause rapid shifts
in blood sugar, Platt said.
Among people in the study who appeared to be needlessly testing
blood sugar at home, about 33,000 individuals were taking
medications that aren't known to cause dangerously low blood sugar
and another 19,000 were not taking any diabetes medicines at all.
Half of the patients doing unnecessary blood sugar tests at home did
these tests at least twice a day, and half of them had testing
supply costs of at least $325 a year, the study found.
[to top of second column] |
The study wasn't a controlled experiment designed to prove whether
or how home testing directly impacted blood sugar levels in people
with diabetes.
And some patients might still need to test at home, even if they
don't need to do this multiple times daily, said Sheri Colberg a
professor emerita at Old Dominion University in Norfolk, Virginia,
who has studied and treated people with diabetes.
"Even if checking routinely may not change outcomes like overall
blood glucose management, the benefit of having glucose testing
strips available is that individuals - even non-insulin users - are
then able to check their blood glucose when their usual routines
vary, during times of illness, or whenever other events may
negatively impact their blood glucose," Colberg, who wasn't involved
in the study, said by email.
Patients should discuss their home blood sugar testing needs at
every checkup, advised Dr. Vanessa Arguello of the David Geffen
School of Medicine at the University of California, Los Angeles.
"Diabetic patients who are using insulin or are on oral medications
that may cause low blood sugars should monitor their blood sugars
multiple times per day including before meals, at bedtime,
occasionally after meals to learn about nutrition therapy, prior to
critical tasks, and when they suspect low blood sugars," Arguello
said by email.
Diabetic patients who are not using insulin or are not taking
medications that may cause low blood sugars can monitor their blood
sugars less frequent from twice daily to every other day based on
their diabetes goals established by the individual and their
physician," Arguello added.
SOURCE: http://bit.ly/2UvbqgE JAMA Internal Medicine, online
December 10, 2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |